We are live on ! Find out more
HCA icon

HCA Healthcare

1,000 hedge funds and large institutions have $41.6B invested in HCA Healthcare in 2023 Q3 according to their latest regulatory filings, with 106 funds opening new positions, 360 increasing their positions, 369 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less repeat investments, than reductions

Existing positions increased: 360 | Existing positions reduced: 369

4% less first-time investments, than exits

New positions opened: 106 | Existing positions closed: 110

1.09% less ownership

Funds ownership: 63.06%61.97% (-1.1%)

1% less funds holding

Funds holding: 1,0131,000 (-13)

11% less call options, than puts

Call options by funds: $509M | Put options by funds: $572M

21% less capital invested

Capital invested by funds: $52.6B → $41.6B (-$11B)

28% less funds holding in top 10

Funds holding in top 10: 3626 (-10)

Holders
1,000
Holders Change
-13
Holders Change %
-1.28%
% of All Funds
15.87%
Holding in Top 10
26
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-27.78%
% of All Funds
0.41%
New
106
Increased
360
Reduced
369
Closed
110
Calls
$509M
Puts
$572M
Net Calls
-$63.1M
Net Calls Change
-$80.9M
Name Holding Trade Value Shares
Change
Change in
Stake
PHP
201
Parkman Healthcare Partners
Connecticut
$13.8M +$15.4M +56,160 New
JMPWA
202
JP Morgan Private Wealth Advisors
California
$13.6M -$1.72M -6,268 -10%
SOMRS
203
State of Michigan Retirement System
Michigan
$13.6M -$410K -1,500 -3%
AB
204
Amalgamated Bank
New York
$13.5M -$316K -1,153 -2%
Calamos Advisors
205
Calamos Advisors
Illinois
$13.5M
WAM
206
Wilson Asset Management
Australia
$13.4M
OIAM
207
OFI Invest Asset Management
France
$13.4M -$174K -636 -1%
DnB Asset Management
208
DnB Asset Management
Norway
$13.1M +$2.23M +8,158 +18%
Nomura Asset Management
209
Nomura Asset Management
Japan
$13.1M -$263K -962 -2%
CC
210
Cannell & Co
New York
$13.1M -$68.4K -250 -0.5%
Stifel Financial
211
Stifel Financial
Missouri
$13M +$1.11M +4,040 +8%
MIM
212
MetLife Investment Management
New Jersey
$12.7M -$679K -2,482 -5%
BTI
213
Blue Trust Inc
Georgia
$12.3M -$141K -515 -1%
SEI Investments
214
SEI Investments
Pennsylvania
$12.2M -$2.16M -7,877 -14%
DMIC
215
Dixon Mitchell Investment Counsel
British Columbia, Canada
$12.2M -$215K -785 -2%
CTI
216
Community Trust & Investment
Kentucky
$12.2M +$39.7K +145 +0.3%
BC
217
Burney Company
Virginia
$12M +$1.09K +4 +0%
UM
218
UniSuper Management
Australia
$11.9M -$4.04M -14,782 -23%
RG
219
Rathbones Group
United Kingdom
$11.7M +$13M +47,597 New
LIA
220
LBMC Investment Advisors
Tennessee
$11.6M +$195K +714 +2%
SLAM
221
Swiss Life Asset Management
$11.5M +$346K +1,265 +3%
EGM
222
Engineers Gate Manager
New York
$11.4M +$12.7M +46,274 New
Retirement Systems of Alabama
223
Retirement Systems of Alabama
Alabama
$11.2M -$378K -1,381 -3%
TAIM
224
Te Ahumairangi Investment Management
New Zealand
$10.9M +$209K +765 +2%
Mirae Asset Global Investments
225
Mirae Asset Global Investments
South Korea
$10.8M +$3.56M +13,019 +42%

HCA Hedge Fund Activity: Q3 2023 in Review

1,000 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q3 2023, worth a combined $41.6B — down 21% from $52.6B a quarter earlier.

Sellers outnumbered buyers: 110 funds closed out of HCA and 106 opened new positions — a net loss of 4 holders — while 369 trimmed existing stakes and 360 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $229M. The largest seller was T. Rowe Price Associates, cutting an estimated $717M.

  • 1,000 institutional investors held HCA Healthcare (HCA) as of Q3 2023, down from 1,013 in Q2 2023.
  • Funds reported $41.6B of HCA Healthcare stock for Q3 2023, down 21% quarter-over-quarter.
  • 106 funds opened new HCA Healthcare positions in Q3 2023 and 110 closed out, a net change of -4 holders.
  • The largest HCA Healthcare buyer in Q3 2023 was Capital World Investors, an estimated $229M added.
  • The largest HCA Healthcare seller in Q3 2023 was T. Rowe Price Associates, an estimated $717M sold.

Based on aggregated 13F filings for Q3 2023.